Dudediligence.

Imunon, Inc

IMNNNASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Net income, by quarter
−$4.8MSep ’24−$4.1MDec ’24−$4.1MMar ’25−$2.7MJun ’25−$3.4MSep ’25$24.8MDec ’25−$4.2MMar ’26−$2.8MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$500,000$500,000none on filenone on filenone on file
Operating income−$21.0M−$24.9M−$21.0M−$19.1M−$14.7M
Net income−$20.8M−$35.9M−$19.5M−$18.6M$14.5M
Operating cash flow−$16.2M−$23.1M−$19.0M−$18.9M−$13.9M
Free cash flow−$16.5M−$23.4M−$19.5M−$18.9M−$14.2M
Cash$19.6M$11.5M$5.8M$5.9M$8.8M
Debtnone on file$6.0Mnone on filenone on filenone on file
Shares outstanding5.8M7.4M9.4M966.7K3.4M